2019/06/28 08:03:40 | |
---|---|
Price | |
0.0085 EUR | |
Difference | 0.00% (0.00) |
ISIN | CH1330780979 |
Symbol | CURE |
Exchange | Frankfurt |
Currency | EUR |
Sector | - |
Security type | Stock |
Market cap (m) | 38 EUR |
Benchmark | SWISS MARKET INDEX |
Bid (Bid size) | - |
Ask (Ask size) | - |
Open | 0.0085 EUR |
High | 0.0085 EUR |
Low | 0.0085 EUR |
Close (prev. day) | 0.0085 EUR |
VWAP | 0.0225 EUR |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 1 |
Last size | 0 |
Related Futures | - |
Related Options | - |
Date | Headline | Download | |
2024/09/11 | Global Equity Ratings | ||
2024/08/12 | Global Equity Ratings | ||
2024/07/12 | Global Equity Ratings | ||
2024/07/03 | Global Strategy 3Q 2024 | ||
2024/06/21 | Global Equity Ratings |
2019/06/28 08:03:40 | |
---|---|
Price | |
0.0085 EUR | |
Difference | 0.00% (0.00) |
ISIN | CH1330780979 |
Symbol | CURE |
Exchange | Frankfurt |
Currency | EUR |
Sector | - |
Security type | Stock |
Market cap (m) | 38 EUR |
Benchmark | SWISS MARKET INDEX |
Bid (Bid size) | - |
Ask (Ask size) | - |
Open | 0.0085 EUR |
High | 0.0085 EUR |
Low | 0.0085 EUR |
Close (prev. day) | 0.0085 EUR |
VWAP | 0.0225 EUR |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 1 |
Last size | 0 |
6m | 1Y | 3Y | |
Perf (%) | - | - | - |
Perf (abs.) | - | - | - |
Beta | -0.97 | 0.71 | 0.28 |
Volatility | - | - | - |
Ø price 5 days | Ø volume 5 days (pcs.) | - EUR (-) |
Ø price 30 days | Ø volume 30 days (pcs.) | - EUR (-) |
Ø price 100 days | Ø volume 100 days (pcs.) | - EUR (-) |
Ø price 250 days | Ø volume 250 days (pcs.) | - EUR (-) |
YTD High | date | - EUR (-) |
YTD Low | date | - EUR (-) |
52 Weeks High | date | - EUR (-) |
52 Weeks Low | date | - EUR (-) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
SIX Swiss Exchange | 2024/09/27 | 09:09 | 7.50 CHF | 0.00 | 5 |
London Stock Exchange | 2018/10/26 | 17:33 | 67.20 CHF | 0.00 | 2 |
Frankfurt | 2019/06/28 | 08:03 | 0.0085 EUR | 0.00 | 1 |
Berlin | 2019/06/28 | 18:47 | 78.40 EUR | 0.00 | 14 |
CURATIS HOLDING AG |
- - |
Weierweg 7 - 4410 Liestal |
Telefon: +41-61-927-87-77 |
Fax: + |
E-mail: info@curatis.com |
Curatis Holding AG operates as a pharmaceutical company. It is engaged in the acquisition, development and commercialization of innovative medicines for the prevention, diagnosis and treatment of rare and specialty care diseases. The company was founded by Gunter Graubach and is headquartered in Liestal, Switzerland. |
Roland Rutschmann | Chairman of Managing Board |
François Bersier | Member of Executive Committee |
Patrick Ramsauer | Member of Executive Committee |
Silvio Inderbitzin | Member of the administrative board |
Günter Graubach | Member of the administrative board |
Marian Borovsky | Chairman of the administrative boar |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer